Trials / Sponsors / Abeona Therapeutics, Inc

Abeona Therapeutics, Inc

Industry · 9 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Active Not Recruiting	A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Trea Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB	Phase 3	2023-04-02
Enrolling By Invitation	A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB RDEB	—	2021-02-09
Terminated	A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101 Mucopolysaccharidosis III-B	—	2020-10-28
Completed	Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa ( Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa	Phase 3	2020-01-10
Terminated	Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB Mucopolysaccharidosis Type 3 B	Phase 1 / Phase 2	2017-10-16
Completed	Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa	Phase 1 / Phase 2	2010-10-05
Completed	A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail Onychomycosis	Phase 2	2006-09-01
Completed	MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers Diabetic Foot Ulcers	Phase 3	1994-08-01
Completed	MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers Diabetic Foot Ulcers	Phase 3	1994-08-01